Risk Materials

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Fabrazyme (agalsidase beta) - Home Infusion HCP Manual - Risk Minimisation Information for Healthcare Professionals

The objective of this document is to provide guidance to healthcare professionals for the management of patients receiving Fabrazyme (agalsidase beta) at home. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

For Healthcare Professionals

Fabrazyme (agalsidase beta) - Home Infusion Patient Manual - Risk Minimisation Information for Patients

The objective of this document is to provide patients with guidance on how to receive Fabrazyme (agalsidase beta) at home. It is the responsibility of the treating physician to supply this material to patients only if the treating physician decides that the patient is eligible for home infusion treatment. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

For Healthcare Professionals

Fabrazyme (agalsidase beta)Home Infusion Patient Logbook- Risk Minimisation Information for Patients

For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

Send us feedback

If you would like to make a comment or send us feedback on this material, click here.